Latest News & Features
Americas
A Virginia judge has approved Par Pharmaceutical’s settlement with a group of direct purchasers, allowing the pharmaceutical company to escape a pay-for-delay lawsuit. 10 March 2020
Big Pharma
EU authorities seized €7.9 million worth of counterfeit medicines—including fake cancer drugs, antivirals, and erectile dysfunction medicines—as part of an operation carried out last year. 9 March 2020
Big Pharma
The search for clarity goes on as Broad gears up for another set of legal challenges, as Claire Irvine, partner at HGF, explains. 6 March 2020
Americas
Drugmakers including Gilead Sciences must face antitrust claims related to HIV drugs, after the US District Court for the District of Florida on Monday, March 3 refused to fully throw out a class-action suit implicating the company. 5 March 2020
Big Pharma
Cooley has grown its IP litigation practice with the addition of partners Sanya Sukduang and Jonathan Davies, who will be based in Washington, DC. 5 March 2020
Americas
Biotech company Bioverativ has accused CSL Behring of infringing three patents covering its haemophilia B treatment Alprolix. 5 March 2020
Asia
India has imposed export restrictions on drugs and active pharmaceutical ingredients (APIs), including paracetamol, amid fears over COVID-19-related shortages. 4 March 2020
Big Pharma
Biotech Thermo Fisher Scientific has announced plans to acquire Dutch diagnostics group Qiagen for $11.5 billion. 3 March 2020
article
April Weisbruch has joined McDermott Will & Emery as an IP partner, moving from Sheppard Mullin Richter & Hampton, where she worked as an IP associate. 3 March 2020
Americas
Gilead Sciences has agreed a $4.9 billion deal to buy California-based immuno-oncology company Forty Seven. 2 March 2020